KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Long-Term Investments (2016 - 2026)

West Pharmaceutical Services has reported Long-Term Investments over the past 18 years, most recently at $209.2 million for Q1 2026.

  • Quarterly Long-Term Investments fell 1.27% to $209.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $209.2 million through Mar 2026, down 1.27% year-over-year, with the annual reading at $212.3 million for FY2025, 5.05% up from the prior year.
  • Long-Term Investments was $209.2 million for Q1 2026 at West Pharmaceutical Services, down from $212.3 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $224.7 million in Q2 2025 and troughed at $188.6 million in Q3 2022.
  • The 5-year median for Long-Term Investments is $208.1 million (2022), against an average of $206.5 million.
  • Biggest five-year swings in Long-Term Investments: decreased 12.56% in 2022 and later rose 13.37% in 2025.
  • Tracing WST's Long-Term Investments over 5 years: stood at $204.9 million in 2022, then grew by 2.49% to $210.0 million in 2023, then fell by 3.76% to $202.1 million in 2024, then rose by 5.05% to $212.3 million in 2025, then fell by 1.46% to $209.2 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $209.2 million, $212.3 million, and $220.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.